|
Real-time Estimate
Cboe BZX
15:18:45 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 9.665 USD | +9.46% |
|
+12.22% | +389.14% |
| 08-10 | ImmunityBio, Inc. Announces Appointment of Dr. Jim Yong Kim as Vice Chairman | CI |
| 08-04 | ImmunityBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 9.36B 8.24B 7.81B 7.05B 13.29B 897B 13.46B 93.42B 35.95B 459B 35.14B 34.37B 1,471B | P/E 2026 * |
-9.2x | P/E 2027 * | -62x |
|---|---|---|---|---|---|
| Enterprise Value | 9.36B 8.24B 7.81B 7.05B 13.29B 897B 13.46B 93.42B 35.95B 459B 35.14B 34.37B 1,471B | EV / Sales 2026 * |
41.5x | EV / Sales 2027 * | 21.2x |
| Free-Float |
37.83% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IBRX | Delayed | |
CBOE
| IBRX | Real-time | |
|
Tradegate
| 26CA | Real-time | |
|
Boerse Muenchen
| 26CA | Real-time | |
|
Börse Stuttgart
| 26CA | Delayed | |
|
Deutsche Boerse AG
| 26CA | Delayed | |
|
Xetra
| 26CA | Delayed |
Last Transcript: ImmunityBio, Inc.
| 1 day | +9.46% | ||
| 1 week | +12.22% | ||
| Current month | +21.82% | ||
| 1 month | +21.82% | ||
| 3 months | +10.62% | ||
| 6 months | +45.42% | ||
| Current year | +389.14% |
| 1 week | 8.26 |  | 10.09 |
| 1 month | 7.64 | | 10.09 |
| Current year | 1.98 | | 12.43 |
| 1 year | 1.95 | | 12.43 |
| 3 years | 1.25 | | 12.43 |
| 5 years | 1.21 | | 12.43 |
| 10 years | 1.21 | | 40.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 57 | 2020-09-30 |
| Chief Executive Officer | 74 | 2015-02-28 | |
David Sachs
DFI | Director of Finance/CFO | 48 | 2021-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Wesley Clark
BRD | Director/Board Member | 80 | 2021-01-31 |
| Director/Board Member | 71 | 2021-02-28 | |
| Chairman | 74 | 2014-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/2/26 | Exercice | Director | 243,168 | 0.0232% | ||
| 7/1/26 | Exercice | Director | 478,434 | 0.0457% | ||
| 6/30/26 | Exercice | Director | 3,000 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.46% | +12.22% | +293.70% | +533.01% | 9.36B | |
| +4.16% | -0.30% | +58.96% | +94.17% | 71.53B | |
| -0.19% | +1.32% | +37.20% | +81.33% | 60.12B | |
| -1.51% | +2.39% | +9.10% | +36.79% | 48.85B | |
| +0.48% | +1.05% | +42.50% | +39.61% | 44.28B | |
| +1.37% | +8.13% | +341.63% | +688.08% | 43.83B | |
| +1.06% | +1.30% | +8.52% | +107.13% | 41.53B | |
| -0.67% | -0.45% | +4.47% | +46.37% | 30.13B | |
| +4.77% | +6.46% | +41.54% | +22.78% | 27.98B | |
| -0.38% | -2.77% | -20.10% | +353.53% | 25.25B | |
| Average | +1.89% | -0.06% | +81.75% | +200.28% | 40.29B | |
| Weighted average by Cap. | +1.36% | +0.50% | +68.62% | +163.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 226M 199M 188M 170M 320M 21.64B 325M 2.25B 867M 11.06B 848M 829M 35.47B | 441M 389M 368M 333M 627M 42.33B 635M 4.41B 1.7B 21.64B 1.66B 1.62B 69.38B |
| Net income | -1B -884M -838M -756M -1.43B -96.27B -1.44B -10.02B -3.86B -49.22B -3.77B -3.69B -158B | -150M -132M -125M -113M -213M -14.41B -216M -1.5B -577M -7.37B -564M -552M -23.62B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | US$9.665 | +9.46% | 21,415,682 |
| 26-09-29 | US$8.830 | +3.64% | 8,366,558 |
| 26-09-28 | US$8.520 | +0.95% | 10,413,580 |
| 26-09-25 | US$8.440 | -2.31% | 5,819,350 |
| 26-09-24 | US$8.640 | +0.12% | 8,980,028 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IBRX Stock
Select your edition
All financial news and data tailored to specific country editions
